A review of the S100 proteins in cancer

Marenholz, 2004, S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature), Biochem Biophys Res Commun, 322, 1111, 10.1016/j.bbrc.2004.07.096

Schafer, 1995, Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family, Genomics, 25, 638, 10.1016/0888-7543(95)80005-7

Donato, 2003, Intracellular and extracellular roles of S100 proteins, Microsc Res Technol, 60, 540, 10.1002/jemt.10296

Moore, 1965, A soluble protein characteristic of the nervous system, Biochem Biophys Res Commun, 19, 739, 10.1016/0006-291X(65)90320-7

Zimmer, 1995, The S100 protein family: history, function, and expression, Brain Res Bull, 37, 417, 10.1016/0361-9230(95)00040-2

Zimmer, 2003, Molecular mechanisms of S100-target protein interactions, Microsc Res Technol, 60, 552, 10.1002/jemt.10297

Mueller, 2005, The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity, J Biol Chem, 280, 29186, 10.1074/jbc.M505000200

Grigorian, 2001, Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction, J Biol Chem, 276, 22699, 10.1074/jbc.M010231200

Santamaria-Kisiel, 2006, Calcium-dependent and -independent interactions of the S100 protein family, Biochem J, 396, 201, 10.1042/BJ20060195

Davies, 1996, Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours, Oncogene, 13, 1631

Kriajevska, 1998, Metastasis-associated Mts1 (S100A4) protein modulates protein kinase C phosphorylation of the heavy chain of nonmuscle myosin, J Biol Chem, 273, 9852, 10.1074/jbc.273.16.9852

Donato, 2001, S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles, Int J Biochem Cell Biol, 33, 637, 10.1016/S1357-2725(01)00046-2

Hiratsuka, 2006, Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis, Nat Cell Biol, 8, 1369, 10.1038/ncb1507

Yen, 1997, Induction of the S100 chemotactic protein, CP-10, in murine microvascular endothelial cells by proinflammatory stimuli, Blood, 90, 4812, 10.1182/blood.V90.12.4812

Cornish, 1996, S100 protein CP-10 stimulates myeloid cell chemotaxis without activation, J Cell Physiol, 166, 427, 10.1002/(SICI)1097-4652(199602)166:2<427::AID-JCP21>3.0.CO;2-6

Devery, 1994, Acute inflammatory activity of the S100 protein CP-10: activation of neutrophils in vivo and in vitro, J Immunol, 152, 1888, 10.4049/jimmunol.152.4.1888

Lau, 1995, A chemotactic S100 peptide enhances scavenger receptor and Mac-1 expression and cholesteryl ester accumulation in murine peritoneal macrophages in vivo, J Clin Invest, 95, 1957, 10.1172/JCI117879

Bonfrer, 1998, The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma, Br J Cancer, 77, 2210, 10.1038/bjc.1998.368

Andres, 2004, Prognostic value of serum S-100B in malignant melanoma, Tumori, 90, 607, 10.1177/030089160409000613

Heizmann, 2004, S100B protein in clinical diagnostics: assay specificity, Clin Chem, 50, 249, 10.1373/clinchem.2003.027367

Zissimopoulos, 2006, Serum levels of S-100b protein after four years follow-up of patients with melanoma, Hell J Nucl Med, 9, 204

Schlagenhauff, 2000, Significance of serum protein S100 levels in screening for melanoma metastasis: does protein S100 enable early detection of melanoma recurrence?, Melanoma Res, 10, 451, 10.1097/00008390-200010000-00007

Harpio, 2004, S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma, Clin Biochem, 37, 512, 10.1016/j.clinbiochem.2004.05.012

Hauschild, 1999, Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy, Br J Dermatol, 140, 1065, 10.1046/j.1365-2133.1999.02905.x

Hauschild, 1999, Prognostic significance of serum S100B detection compared with routine blood parameters in advanced metastatic melanoma patients, Melanoma Res, 9, 155, 10.1097/00008390-199904000-00008

Schultz, 1998, Clinical and prognostic relevance of serum S-100 beta protein in malignant melanoma, Br J Dermatol, 138, 426, 10.1046/j.1365-2133.1998.02119.x

Hamberg, 2003, Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma, Melanoma Res, 13, 45, 10.1097/00008390-200302000-00008

Smit, 2005, Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients, Eur J Cancer, 41, 386, 10.1016/j.ejca.2004.10.019

Guo, 1995, Clinical significance of serum S100 in metastatic malignant melanoma, Eur J Cancer, 31A, 1898, 10.1016/0959-8049(95)00087-Y

Davies, 2002, Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer, J Pathol, 196, 292, 10.1002/path.1051

Wang, 2000, Interaction in vivo and in vitro of the metastasis-inducing S100 protein, S100A4 (p9Ka) with S100A1, J Biol Chem, 275, 11141, 10.1074/jbc.275.15.11141

Nikitenko, 2000, Localisation by in situ hybridisation of S100A4 (p9Ka) mRNA in primary human breast tumour specimens, Int J Cancer, 86, 219, 10.1002/(SICI)1097-0215(20000415)86:2<219::AID-IJC11>3.0.CO;2-7

Barraclough, 1998, Calcium-binding protein S100A4 in health and disease, Biochim Biophys Acta, 1448, 190, 10.1016/S0167-4889(98)00143-8

Takenaga, 1997, Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas, Clin Cancer Res, 3, 2309

Zou, 2005, S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma, Br J Cancer, 93, 1277, 10.1038/sj.bjc.6602856

Zou, 2004, Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis: identification of S100A4 (Mts1) gene overexpression as a poor prognostic marker for thyroid carcinoma, J Clin Endocrinol Metab, 89, 6146, 10.1210/jc.2004-0418

Belot, 2002, Extracellular S100A4 stimulates the migration rate of astrocytic tumor cells by modifying the organization of their actin cytoskeleton, Biochim Biophys Acta, 1600, 74, 10.1016/S1570-9639(02)00447-8

Cho, 2003, Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer, Apmis, 111, 539, 10.1034/j.1600-0463.2003.1110502.x

Kimura, 2000, Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer, Int J Oncol, 16, 1125

Gupta, 2003, Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma, J Clin Oncol, 21, 106, 10.1200/JCO.2003.03.024

Saleem, 2006, S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9, Proc Natl Acad Sci U S A, 103, 14825, 10.1073/pnas.0606747103

Andersen, 2004, Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma, Mod Pathol, 17, 990, 10.1038/modpathol.3800151

Ambartsumian, 1996, Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene, Oncogene, 13, 1621

Grigorian, 2003, Genetika, 39, 900

Lee, 2004, Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer, Oncology, 66, 429, 10.1159/000079496

Gongoll, 2002, Prognostic significance of calcium-binding protein S100A4 in colorectal cancer, Gastroenterology, 123, 1478, 10.1053/gast.2002.36606

Hemandas, 2006, Metastasis-associated protein S100A4 – a potential prognostic marker for colorectal cancer, J Surg Oncol, 93, 498, 10.1002/jso.20460

Flatmark, 2003, Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer, J Pathol, 200, 589, 10.1002/path.1381

Yonemura, 2000, Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer, Clin Cancer Res, 6, 4234

Barraclough, 1998, Use of DNA transfer in the induction of metastasis in experimental mammary systems, Biochem Soc Symp, 63, 273

Davies, 1993, Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the Oncogene EJ-ras-1, Oncogene, 8, 999

Davies, 1993, Production of the metastatic phenotype by DNA transfection in a rat mammary model, Cell Biol Int, 17, 871, 10.1006/cbir.1993.1150

Levett, 2002, Transfection of S100A4 produces metastatic variants of an orthotopic model of bladder cancer, Am J Pathol, 160, 693, 10.1016/S0002-9440(10)64889-4

Lloyd, 1998, Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells, Oncogene, 17, 465, 10.1038/sj.onc.1201948

Mathisen, 2003, S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells, Clin Exp Metastasis, 20, 701, 10.1023/B:CLIN.0000006819.21361.03

Bjornland, 1999, S100A4 involvement in metastasis. deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme, Cancer Res, 59, 4702

Kriajevska, 1994, Non-muscle myosin heavy chain as a possible target for protein encoded by metastasis-related mts-1 gene, J Biol Chem, 269, 19679, 10.1016/S0021-9258(17)32072-0

Li, 2006, The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA, Cancer Res, 66, 5173, 10.1158/0008-5472.CAN-05-3087

Dulyaninova, 2005, Regulation of myosin-IIA assembly and Mts1 binding by heavy chain phosphorylation, Biochemistry, 44, 6867, 10.1021/bi0500776

Li, 2003, Mts1 regulates the assembly of nonmuscle myosin-IIA, Biochemistry, 42, 14258, 10.1021/bi0354379

Mandinova, 1998, Distinct subcellular localization of calcium binding S100 proteins in human smooth muscle cells and their relocation in response to rises in intracellular calcium, J Cell Sci, 111, 2043, 10.1242/jcs.111.14.2043

Takenaga, 1994, Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosin, J Cell Biol, 124, 757, 10.1083/jcb.124.5.757

Takenaga, 1994, Restoration of microfilament bundle organization in v-raf-transformed NRK cells after transduction with tropomyosin 2 cDNA, Cancer Lett, 87, 47, 10.1016/0304-3835(94)90408-1

Maelandsmo, 1997, Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma, Int J Cancer, 74, 464, 10.1002/(SICI)1097-0215(19970822)74:4<464::AID-IJC19>3.0.CO;2-9

Feng, 2001, Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis, Cancer Res, 61, 7999

Suzuki, 2005, S100A2 expression as a predictive marker for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral cavity, Oncol Rep, 14, 1493

Liu, 2000, Expression of calcium-binding protein S100A2 in breast lesions, Br J Cancer, 83, 1473, 10.1054/bjoc.2000.1488

Lee, 1992, Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment, Proc Natl Acad Sci U S A, 89, 2504, 10.1073/pnas.89.6.2504

Kyriazanos, 2002, Expression and prognostic significance of S100A2 protein in squamous cell carcinoma of the esophagus, Oncol Rep, 9, 503

Tsai, 2005, S100A2, a potential marker for early recurrence in early-stage oral cancer, Oral Oncol, 41, 349, 10.1016/j.oraloncology.2004.09.006

Smith, 2004, S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas, Br J Cancer, 91, 1515, 10.1038/sj.bjc.6602188

Zech, 2006, Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer, Cancer Detect Prev, 30, 395, 10.1016/j.cdp.2006.04.009

Imazawa, 2005, S100A2 overexpression is frequently observed in esophageal squamous cell carcinoma, AntiCancer Res, 25, 1247

Ito, 2005, Expression of S100A2 and S100A6 in thyroid carcinomas, Histopathology, 46, 569, 10.1111/j.1365-2559.2005.02137.x

Tsai, 2006, Cyclooxygenase-2 is involved in S100A2-mediated tumor suppression in squamous cell carcinoma, Mol Cancer Res, 4, 539, 10.1158/1541-7786.MCR-05-0266

Madsen, 1992, Molecular cloning and expression of a novel keratinocyte protein (psoriasis-associated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acid-binding proteins, J Invest Dermatol, 99, 299, 10.1111/1523-1747.ep12616641

Madsen, 1991, Molecular cloning, occurrence, and expression of a novel partially secreted protein “psoriasin” that is highly up-regulated in psoriatic skin, J Invest Dermatol, 97, 701, 10.1111/1523-1747.ep12484041

Moog-Lutz, 1995, Comparative expression of the psoriasin (S100A7) and S100C genes in breast carcinoma and co-localization to human chromosome 1q21-q22, Int J Cancer, 63, 297, 10.1002/ijc.2910630225

Celis, 1996, Bladder squamous cell carcinomas express psoriasin and externalize it to the urine, J Urol, 155, 2105, 10.1016/S0022-5347(01)66118-4

Moubayed, 2007, Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours, J Cancer Res Clin Oncol, 133, 253, 10.1007/s00432-006-0164-y

Emberley, 2003, Psoriasin interacts with Jab1 and influences breast cancer progression, Cancer Res, 63, 1954

Emberley, 2003, Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer, Clin Cancer Res, 9, 2627

Emberley, 2004, S100 proteins and their influence on pro-survival pathways in cancer, Biochem Cell Biol, 82, 508, 10.1139/o04-052

Leygue, 1996, Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma, Cancer Res, 56, 4606

Al-Haddad, 1999, Psoriasin (S100A7) expression and invasive breast cancer, Am J Pathol, 155, 2057, 10.1016/S0002-9440(10)65524-1

Emberley, 2004, S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast, Breast Cancer Res, 6, R308, 10.1186/bcr791

Salama, 2006, S100A7 and the basal phenotype, Eur J Surg Oncol, 32, 262, 10.1016/S0748-7983(06)70697-7

Krop, 2005, A putative role for psoriasin in breast tumor progression, Cancer Res, 65, 11326, 10.1158/0008-5472.CAN-05-1523

Kennedy, 2005, BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene, Cancer Res, 65, 10265, 10.1158/0008-5472.CAN-05-1841

Vogl, 2006, Biophysical characterization of S100A8 and S100A9 in the absence and presence of bivalent cations, Biochim Biophys Acta, 1763, 1298, 10.1016/j.bbamcr.2006.08.028

Yong, 2007, Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells, Arch Pharm Res, 30, 75, 10.1007/BF02977781

Hermani, 2006, S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells, Exp Cell Res, 312, 184, 10.1016/j.yexcr.2005.10.013

Stulik, 1999, Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma, Electrophoresis, 20, 3638, 10.1002/(SICI)1522-2683(19991201)20:18<3638::AID-ELPS3638>3.0.CO;2-W

Stulik, 1999, The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: the S100A9 and S100A8 positive cells underlie and invade tumor mass, Electrophoresis, 20, 1047, 10.1002/(SICI)1522-2683(19990101)20:4/5<1047::AID-ELPS1047>3.0.CO;2-E

Cross, 2005, Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers, Histopathology, 46, 256, 10.1111/j.1365-2559.2005.02097.x

Mulligan, 2005, The role of S100A9 in mediating the breast myoepithelial tumour-suppressor effect, J Pathol, 207, 27A

Rafii, 2006, S100 chemokines mediate bookmarking of premetastatic niches, Nat Cell Biol, 8, 1321, 10.1038/ncb1206-1321

Memon, 2005, Down-regulation of S100C is associated with bladder cancer progression and poor survival, Clin Cancer Res, 11, 606, 10.1158/1078-0432.606.11.2

Kondo, 2002, Localization of S100C immunoreactivity in various human tissues, Acta Med Okayama, 56, 31

Rehman, 2004, Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions, Hum Pathol, 35, 1385, 10.1016/j.humpath.2004.07.015

Ito, 2004, S100A4 expression is an early event of papillary carcinoma of the thyroid, Oncology, 67, 397, 10.1159/000082924

Shi, 2006, Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse model, J Clin Endocrinol Metab, 91, 2373, 10.1210/jc.2006-0155

Ito, 2005, S100A9 expression is significantly linked to dedifferentiation of thyroid carcinoma, Pathol Res Pract, 201, 551, 10.1016/j.prp.2005.08.003

Puskas, 2005, Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors, Cell Mol Biol (Noisy-le-grand), 51, 177

Li, 2005, S100A1 and KIT gene expressions in common subtypes of renal tumours, Eur J Surg Oncol, 31, 299, 10.1016/j.ejso.2004.11.009

Lin, 2006, Expression of S-100 protein in renal cell neoplasms, Hum Pathol, 37, 462, 10.1016/j.humpath.2005.12.008

Carlsson, 2005, Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development, Int J Oncol, 27, 1473

Jiang, 2004, Psoriasin is aberrantly expressed in human breast cancer and is related to clinical outcomes, Int J Oncol, 25, 81

Alowami, 2003, Psoriasin (S100A7) expression is altered during skin tumorigenesis, BMC Dermatol, 3, 1, 10.1186/1471-5945-3-1

Emberley, 2002, RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer, BMC Cancer, 2, 28, 10.1186/1471-2407-2-28

Enerback, 2002, Psoriasin expression in mammary epithelial cells in vitro and in vivo, Cancer Res, 62, 43

Emberley, 2004, S100A7 and the progression of breast cancer, Breast Cancer Res, 6, 153, 10.1186/bcr816

Celis, 2006, Molecular pathology of breast apocrine carcinomas: a protein expression signature specific for benign apocrine metaplasia, FEBS Lett, 580, 2935, 10.1016/j.febslet.2006.03.080

Arai, 2004, S100A9 expression in invasive ductal carcinoma of the breast: S100A9 expression in adenocarcinoma is closely associated with poor tumour differentiation, Eur J Cancer, 40, 1179, 10.1016/j.ejca.2004.01.022

Arnes, 2005, Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer, Clin Cancer Res, 11, 4003, 10.1158/1078-0432.CCR-04-2064

Stulik, 2000, Differential expression of the Ca2+ binding S100A6 protein in normal, preneoplastic and neoplastic colon mucosa, Eur J Cancer, 36, 1050, 10.1016/S0959-8049(00)00043-5

Komatsu, 2000, Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas, Clin Cancer Res, 6, 172

Melle, 2006, Different expression of calgizzarin (S100A11) in normal colonic epithelium, adenoma and colorectal carcinoma, Int J Oncol, 28, 195

Tanaka, 1995, Human calgizzarin; one colorectal cancer-related gene selected by a large scale random cDNA sequencing and northern blot analysis, Cancer Lett, 89, 195, 10.1016/0304-3835(94)03687-E

Cho, 2005, Overexpression of S100A4 is closely associated with progression of colorectal cancer, World J Gastroenterol, 11, 4852, 10.3748/wjg.v11.i31.4852

Komatsu, 2002, Expression of S100A6 and S100A4 in matched samples of human colorectal mucosa, primary colorectal adenocarcinomas and liver metastases, Oncology, 63, 192, 10.1159/000063812

Komatsu, 2000, Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma, Br J Cancer, 83, 769, 10.1054/bjoc.2000.1356

Tolson, 2006, Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis, Proteomics, 6, 697, 10.1002/pmic.200500033

Agerbaek, 2006, Focal S100A4 protein expression is an independent predictor of development of metastatic disease in cystectomized bladder cancer patients, Eur Urol, 50, 777, 10.1016/j.eururo.2006.02.027

Davies, 2003, Gene products involved in metastasis of bladder cancer, Histol Histopathol, 18, 969

Rehman, 2005, Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer, Prostate, 65, 322, 10.1002/pros.20302

Heighway, 2002, Expression profiling of primary non-small cell lung cancer for target identification, Oncogene, 21, 7749, 10.1038/sj.onc.1205979

Matsubara, 2005, Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes, Cancer Sci, 96, 844, 10.1111/j.1349-7006.2005.00121.x

Wang, 2005, Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer, Int J Cancer, 116, 285, 10.1002/ijc.21035

Shimada, 2005, Establishment of an immortalized cell line from a precancerous lesion of lung adenocarcinoma, and genes highly expressed in the early stages of lung adenocarcinoma development, Cancer Sci, 96, 668, 10.1111/j.1349-7006.2005.00100.x

Mori, 2004, S100A11 gene identified by in-house cDNA microarray as an accurate predictor of lymph node metastases of gastric cancer, Oncol Rep, 11, 1287

Lee, 2006, Expression of calcium-binding proteins S100A2 and S100A4 in Barrett's adenocarcinomas, Neoplasia, 8, 843, 10.1593/neo.06481